1st Quarter - Report
SAREPTA THERAPEUTICS, INC. for SAREPTA THERAPEUTICS, INC.
Client
Income
—
Expenses
$320,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to patient access to treatments Issues related to rare diseases such as Duchenne Muscular Dystrophy Issues related to newborn screening for rare diseases
| Lobbyist | Covered position, as disclosed |
|---|---|
| KIP PAYNE | — |
Pharmacy PHA
Issues related to the Inflation Reduction Acts prescription drug provisions
| Lobbyist | Covered position, as disclosed |
|---|---|
| KIP PAYNE | — |
Science/Technology SCI
Issues related to scientific innovation in healthcare such as gene therapies Issues related to artificial intelligence and data governance
| Lobbyist | Covered position, as disclosed |
|---|---|
| KIP PAYNE | — |
Taxation/Internal Revenue Code TAX
Tax issues related to research and development
| Lobbyist | Covered position, as disclosed |
|---|---|
| KIP PAYNE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.